Simplex Trading’s Juniper Pharmaceuticals, Inc. Common Stock JNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-15,474
Closed -$134K 8559
2018
Q2
$134K Buy
15,474
+15,235
+6,374% +$137K ﹤0.01% 3954
2018
Q1
$2K Buy
+239
New +$2.01K ﹤0.01% 5475
2017
Q4
Sell
-1,437
Closed -$6K 7190
2017
Q3
$6K Buy
+1,437
New +$6.75K ﹤0.01% 4312
2016
Q4
Sell
-13,330
Closed -$73.2K 6981
2016
Q3
$73K Buy
13,330
+294
+2% +$1.94K ﹤0.01% 1799
2016
Q2
$91K Buy
13,036
+3,045
+30% +$21.5K 0.01% 1548
2016
Q1
$66K Buy
9,991
+5,086
+104% +$37.4K 0.01% 1720
2015
Q4
$50K Sell
4,905
-5,237
-52% -$60.7K ﹤0.01% 1926
2015
Q3
$119K Buy
10,142
+4,542
+81% +$50.2K 0.01% 1291
2015
Q2
$51K Buy
+5,600
New +$42.3K ﹤0.01% 1695

Simplex Trading's JNP Position: Q3 2018 in Review

Simplex Trading sold out of Juniper Pharmaceuticals, Inc. Common Stock (JNP) in Q3 2018, closing a stake of 15,474 shares — an estimated $134K sold.

Simplex Trading first reported a position in JNP in Q2 2015 and held it in 9 quarters. The position peaked at $134K in Q2 2018. 0 funds tracked by Wall St. Rank hold JNP as of Q3 2018.

  • Simplex Trading reported no remaining Juniper Pharmaceuticals, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
  • Simplex Trading sold 15,474 Juniper Pharmaceuticals, Inc. Common Stock shares in Q3 2018, an estimated $134K.
  • Simplex Trading first reported a position in Juniper Pharmaceuticals, Inc. Common Stock in Q2 2015 and held it in 9 quarters.
  • Simplex Trading's Juniper Pharmaceuticals, Inc. Common Stock position peaked at $134K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Juniper Pharmaceuticals, Inc. Common Stock as of Q3 2018.

Based on Simplex Trading's 13F filing for Q3 2018, filed 23 Oct 2018.